O
ONKURE THERAPEUTICS, INC.
NASDAQ: OKUR (OnKure Therapeutics, Inc.)
最近更新时间: 2小时之前2.62
0.00 (0.00%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | OnKure Therapeutics, Inc. | 混合的 | 混合的 |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | 0.8 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 相对估值 | NA |
| 财务健康 | 0.0 |
| 宏观环境 | -0.3 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | 0.92 |
|
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 1.57% |
| 机构持股比例 | 98.08% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Ra Capital Management, L.P. | 30 Jun 2026 | 3,998,333 |
| Acorn Capital Advisors, Llc | 30 Jun 2026 | 2,839,674 |
| Stepstone Group Lp | 30 Jun 2026 | 2,660,612 |
| Adar1 Capital Management, Llc | 30 Jun 2026 | 2,238,684 |
| Vivo Capital, Llc | 30 Jun 2026 | 1,927,710 |
| Vestal Point Capital, Lp | 30 Jun 2026 | 1,825,699 |
| Trails Edge Capital Partners, Lp | 30 Jun 2026 | 1,438,456 |
| Sio Capital Management, Llc | 30 Jun 2026 | 1,078,965 |
| Prosight Management, Lp | 30 Jun 2026 | 978,992 |
| Logos Global Management Lp | 30 Jun 2026 | 963,855 |
该时间范围内无数据。
投资组合